메뉴 건너뛰기




Volumn 83, Issue 3, 2017, Pages 476-486

Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949

Author keywords

biomarker; cytokines; dose finding; FACS; first in class; flow cytometry; FPR2 ALX; inflammation; LPS challenge; sputum

Indexed keywords

ACT 389949; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ACT-389949; CYTOKINE; FORMYLPEPTIDE RECEPTOR; FPR2 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; LIPOXIN RECEPTOR; OXAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE;

EID: 85001946006     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.13149     Document Type: Review
Times cited : (51)

References (34)
  • 1
    • 84976865494 scopus 로고    scopus 로고
    • The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
    • Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP, et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 2016; 44 (Database Issue): D1054–D1068.
    • (2016) Nucl Acids Res , vol.44 , Issue.Database Issue , pp. D1054-D1068
    • Southan, C.1    Sharman, J.L.2    Benson, H.E.3    Faccenda, E.4    Pawson, A.J.5    Alexander, S.P.6
  • 3
    • 77957325778 scopus 로고    scopus 로고
    • Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?
    • Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010; 177: 1576–1591.
    • (2010) Am J Pathol , vol.177 , pp. 1576-1591
    • Serhan, C.N.1
  • 4
    • 84946196935 scopus 로고    scopus 로고
    • Resolution pharmacology: opportunities for therapeutic innovation in inflammation
    • Perretti M, Leroy X, Bland EJ, Montero-Melendez T. Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 2015; 36: 737–755.
    • (2015) Trends Pharmacol Sci , vol.36 , pp. 737-755
    • Perretti, M.1    Leroy, X.2    Bland, E.J.3    Montero-Melendez, T.4
  • 5
    • 84961761119 scopus 로고    scopus 로고
    • Resolution of inflammation: a new therapeutic frontier
    • Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov 2016; 15: 551–567.
    • (2016) Nat Rev Drug Discov , vol.15 , pp. 551-567
    • Fullerton, J.N.1    Gilroy, D.W.2
  • 7
    • 34248196011 scopus 로고    scopus 로고
    • New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications
    • Chiang N, Serhan CN. New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. Compr Ther 2006; 32: 150–157.
    • (2006) Compr Ther , vol.32 , pp. 150-157
    • Chiang, N.1    Serhan, C.N.2
  • 8
    • 58149094363 scopus 로고    scopus 로고
    • Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
    • Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9: 62–70.
    • (2009) Nat Rev Immunol , vol.9 , pp. 62-70
    • Perretti, M.1    D'Acquisto, F.2
  • 9
    • 3042856569 scopus 로고    scopus 로고
    • A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands
    • Kostenis E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther 2004; 102: 243–257.
    • (2004) Pharmacol Ther , vol.102 , pp. 243-257
    • Kostenis, E.1
  • 11
    • 33751211223 scopus 로고    scopus 로고
    • Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses
    • Migeotte I, Communi D, Parmentier M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 2006; 17: 501–519.
    • (2006) Cytokine Growth Factor Rev , vol.17 , pp. 501-519
    • Migeotte, I.1    Communi, D.2    Parmentier, M.3
  • 12
    • 84879091724 scopus 로고    scopus 로고
    • Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor
    • Dalli J, Consalvo AP, Ray V, Di Filippo C, D'Amico M, Mehta N, et al. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor. J Immunol 2013; 190: 6478–6487.
    • (2013) J Immunol , vol.190 , pp. 6478-6487
    • Dalli, J.1    Consalvo, A.P.2    Ray, V.3    Di Filippo, C.4    D'Amico, M.5    Mehta, N.6
  • 13
    • 84864743193 scopus 로고    scopus 로고
    • Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis
    • Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC, et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 2012; 92: 249–258.
    • (2012) J Leukoc Biol , vol.92 , pp. 249-258
    • Vago, J.P.1    Nogueira, C.R.2    Tavares, L.P.3    Soriani, F.M.4    Lopes, F.5    Russo, R.C.6
  • 14
    • 77951902950 scopus 로고    scopus 로고
    • Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation
    • Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, et al. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 2010; 184: 2611–2619.
    • (2010) J Immunol , vol.184 , pp. 2611-2619
    • Dufton, N.1    Hannon, R.2    Brancaleone, V.3    Dalli, J.4    Patel, H.B.5    Gray, M.6
  • 15
    • 0037441872 scopus 로고    scopus 로고
    • Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R
    • He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003; 101: 1572–1581.
    • (2003) Blood , vol.101 , pp. 1572-1581
    • He, R.1    Sang, H.2    Ye, R.D.3
  • 16
    • 84898927023 scopus 로고    scopus 로고
    • A membrane-tethering pepducin that inhibits formyl peptide receptor 2-induced signaling
    • Lee HY, Kim H, Lee SY, Jung YS, Kim SD, Bae YS. A membrane-tethering pepducin that inhibits formyl peptide receptor 2-induced signaling. Pharmazie 2014; 69: 293–296.
    • (2014) Pharmazie , vol.69 , pp. 293-296
    • Lee, H.Y.1    Kim, H.2    Lee, S.Y.3    Jung, Y.S.4    Kim, S.D.5    Bae, Y.S.6
  • 17
    • 0029094562 scopus 로고
    • Assessment of dose proportionality: report from the statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party
    • Gough K, Hutchison M, Keene O, Byrom B, Ellis S, Lacey L, et al. Assessment of dose proportionality: report from the statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party. Ther Innov Regul Sci 1995; 29: 1039–1048.
    • (1995) Ther Innov Regul Sci , vol.29 , pp. 1039-1048
    • Gough, K.1    Hutchison, M.2    Keene, O.3    Byrom, B.4    Ellis, S.5    Lacey, L.6
  • 18
    • 84861418098 scopus 로고    scopus 로고
    • LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2
    • Aul R, Patel S, Summerhill S, Kilty I, Plumb J, Singh D. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Int Immunopharmacol 2012; 13: 225–231.
    • (2012) Int Immunopharmacol , vol.13 , pp. 225-231
    • Aul, R.1    Patel, S.2    Summerhill, S.3    Kilty, I.4    Plumb, J.5    Singh, D.6
  • 19
    • 84976307749 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic modelling of receptor internalization with CRTH2 antagonists to optimize dose selection
    • Krause A, Zisowsky J, Strasser DS, Gehin M, Sidharta PN, Groenen PM, et al. Pharmacokinetic/pharmacodynamic modelling of receptor internalization with CRTH2 antagonists to optimize dose selection. Clin Pharmacokinet 2016; 55: 813–821.
    • (2016) Clin Pharmacokinet , vol.55 , pp. 813-821
    • Krause, A.1    Zisowsky, J.2    Strasser, D.S.3    Gehin, M.4    Sidharta, P.N.5    Groenen, P.M.6
  • 20
    • 78649338158 scopus 로고    scopus 로고
    • FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
    • Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M, et al. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. FASEB J 2010; 24: 4240–4249.
    • (2010) FASEB J , vol.24 , pp. 4240-4249
    • Maderna, P.1    Cottell, D.C.2    Toivonen, T.3    Dufton, N.4    Dalli, J.5    Perretti, M.6
  • 21
    • 0038487327 scopus 로고    scopus 로고
    • The ins and outs of G protein-coupled receptor trafficking
    • Marchese A, Chen C, Kim YM, Benovic JL. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci 2003; 28: 369–376.
    • (2003) Trends Biochem Sci , vol.28 , pp. 369-376
    • Marchese, A.1    Chen, C.2    Kim, Y.M.3    Benovic, J.L.4
  • 22
    • 84876004456 scopus 로고    scopus 로고
    • Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists
    • Cattaneo F, Parisi M, Ammendola R. Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists. Int J Mol Sci 2013; 14: 7193–7230.
    • (2013) Int J Mol Sci , vol.14 , pp. 7193-7230
    • Cattaneo, F.1    Parisi, M.2    Ammendola, R.3
  • 23
  • 24
    • 84922212387 scopus 로고    scopus 로고
    • Plasma levels of IL-37 and correlation with TNF-alpha, IL-17 A, and disease activity during DMARD treatment of rheumatoid arthritis
    • Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF. Plasma levels of IL-37 and correlation with TNF-alpha, IL-17 A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 2014; 9: e95346.
    • (2014) PLoS One , vol.9
    • Zhao, P.W.1    Jiang, W.G.2    Wang, L.3    Jiang, Z.Y.4    Shan, Y.X.5    Jiang, Y.F.6
  • 25
    • 84926023016 scopus 로고    scopus 로고
    • An enhanced ELISPOT assay for sensitive detection of antigen-specific T cell responses to Borrelia burgdorferi
    • Jin C, Roen DR, Lehmann PV, Kellermann GH. An enhanced ELISPOT assay for sensitive detection of antigen-specific T cell responses to Borrelia burgdorferi. Cells 2013; 2: 607–620.
    • (2013) Cells , vol.2 , pp. 607-620
    • Jin, C.1    Roen, D.R.2    Lehmann, P.V.3    Kellermann, G.H.4
  • 26
    • 84890290253 scopus 로고    scopus 로고
    • Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist
    • Leaker BR, Barnes PJ, O'Connor B. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist. Respir Res 2013; 14: 137.
    • (2013) Respir Res , vol.14 , pp. 137
    • Leaker, B.R.1    Barnes, P.J.2    O'Connor, B.3
  • 27
    • 69249202368 scopus 로고    scopus 로고
    • Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure
    • Duringer C, Grundstrom G, Gurcan E, Dainty IA, Lawson M, Korn SH, et al. Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure. Br J Pharmacol 2009; 158: 169–179.
    • (2009) Br J Pharmacol , vol.158 , pp. 169-179
    • Duringer, C.1    Grundstrom, G.2    Gurcan, E.3    Dainty, I.A.4    Lawson, M.5    Korn, S.H.6
  • 29
    • 79955631465 scopus 로고    scopus 로고
    • Agonist-directed desensitization of the beta2-adrenergic receptor
    • Goral V, Jin Y, Sun H, Ferrie AM, Wu Q, Fang Y. Agonist-directed desensitization of the beta2-adrenergic receptor. PLoS One 2011; 6: e19282.
    • (2011) PLoS One , vol.6
    • Goral, V.1    Jin, Y.2    Sun, H.3    Ferrie, A.M.4    Wu, Q.5    Fang, Y.6
  • 30
    • 78751498756 scopus 로고    scopus 로고
    • Functional selectivity and biased receptor signaling
    • Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 2011; 336: 296–302.
    • (2011) J Pharmacol Exp Ther , vol.336 , pp. 296-302
    • Kenakin, T.1
  • 31
    • 77952354490 scopus 로고    scopus 로고
    • Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery
    • Kenakin T, Miller LJ. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010; 62: 265–304.
    • (2010) Pharmacol Rev , vol.62 , pp. 265-304
    • Kenakin, T.1    Miller, L.J.2
  • 34
    • 66249144426 scopus 로고    scopus 로고
    • The structure and function of G-protein-coupled receptors
    • Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009; 459: 356–363.
    • (2009) Nature , vol.459 , pp. 356-363
    • Rosenbaum, D.M.1    Rasmussen, S.G.2    Kobilka, B.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.